We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Conor Medsystems presented 12-month follow-up data from its PISCES (Paclitaxel
In-Stent Controlled Elution Study) clinical trial at the American College of
Cardiology scientific session in Orlando, Fla., that supported the long-term
safety and efficacy of Conor's novel cardiovascular stent technology.
Sutura has announced the completion of a successful audit leading to a number
of certifications for the manufacture of the company's SuperStitch closure product
line.
Rapid dermal anesthesia was achieved in a study using Sontra Medical's SonoPrep
ultrasonic skin permeation followed by two minutes of active drug transport
with iontophoresis, a needle-free method of delivering drugs through the skin
using low-level electrical current, the company said.
Novadaq Technologies announced
that Nimesh Desai and Stephen Fremes reported data on a 120-patient prospective
study conducted at Sunnybrook and Women's College Health Sciences Centre in
Toronto, Canada, using Novadaq's proprietary Spy Intra-operative Imaging System
for the assessment of graft quality during Coronary Artery Bypass Surgery (CABG).
Ambion Diagnostics, a division of Ambion, has entered into a new agreement with
Wyeth Pharmaceuticals to continue its alliance in the development and supply
of cGMP-grade RNA that will be incorporated as a component in Wyeth's innovative
vaccine program.
Biomet announced that the FDA has granted marketing clearance for its patented
ArComXL Highly Crosslinked Polyethylene, an engineered polymer that has demonstrated
a 47 percent to 64 percent volumetric wear rate reduction over Biomet's own
ArCom Polyethylene.
EP MedSystems, a maker of electrophysiology products used in cardiac rhythm
management, began shipping certain EP catheters to its customers from its offshore
manufacturing efforts in Mexico.
ZymeQuest, a company that discovers, develops and commercializes carbohydrate-modified
blood products for use in transfusion medicine, has exercised its option to
license worldwide rights to a new method of treating platelets developed by
Brigham and Women's Hospital.
Fresh off a U.S. Patent and Trademark Office ruling that overturned a patent
related to the collection and preservation of stem cells, ThermoGenesis - which
makes equipment used to store such cells -- has asked the government to
consider rejecting the claims made in two more.
Cholestech announced the introduction of the Cholestech LDX high sensitivity
C-Reactive Protein (hs-CRP) test at the 54th Annual Scientific Session of the
American College of Cardiology.